Trailing-twelve-month (TTM) revenue is $29.43 Billion with a year-over-year growth of +2.35%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $6,702,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $8,470,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-04-07 | $7,347,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-09 |
| Q2 FY2026Period ended 2026-06-30 | $6,913,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $29,432,000,000 |
Current P/S: $11,105,110,700 market capitalization ÷ $29,432,000,000 TTM revenue = 0.38x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.91B.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:54.837Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Advertising | $6.2B | $11.1B | $9.8B | $9.3B | $10.9B | $10.3B |
| Affiliate And Subscription | $4.0B | $8.6B | $9.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $2.5B | $5.7B | $4.6B | $5.3B | $5.7B | $5.5B |
| UNITED STATES | $12.0B | $22.2B | $20.7B | $23.3B |
$29.43B
$29.43 Billion
+2.35%
vs. $28.76B a year ago (TTM)
+2.35%
1 Year compound annual growth rate
1 Year
+2.35%
3 Year
N/A
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $29.21B | $0 | +0.00% |
| 2024 | $29.21B | ($439.00M) | (1.48%) |
TTM Growth
+2.35%
3-Year CAGR
N/A
5-Year CAGR
N/A
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:54.837Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $11.6B |
| $13.2B |
| Licensing And Other | N/A | $6.5B | $6.0B | N/A | $6.5B | $5.0B |
|---|
| Publishing Segment | $825M | $814M | N/A | N/A | N/A | N/A |
|---|
| Theatrical | N/A | $547M | $180M | $241M | $1.2B | $813M |
|---|
| $23.7B |
